SRPT

Sarepta Therapeutics, Inc. Press Releases

$17.925
*  
0.445
2.55%
Get SRPT Alerts
*Delayed - data as of May 24, 2016 12:43 ET  -  Find a broker to begin trading SRPT now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    SRPT Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing

CORRECTING and REPLACING Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
5/10/2016 5:08:00 PM - Business Wire
▲0.99 % Price Change since this news event. The Volume Ratio is 0.33.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Sarepta Therapeutics Announces First Quarter 2016 Financial Results and Recent Corporate Developments
5/5/2016 7:00:00 AM - Business Wire
▲5.32 % Price Change since this news event. The Volume Ratio is 0.55.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day








Sarepta Issues Statement on Advisory Committee Outcome for Use of Eteplirsen in the Treatment of Duchenne Muscular Dystrophy
4/25/2016 10:58:00 PM - Business Wire
▲12.03 % Price Change since this news event. The Volume Ratio is 4.02.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Market Exclusive Research Weekly Biotech Report
4/18/2016 9:27:00 AM - AccessWire






Sarepta Therapeutics Announces FDA Advisory Committee Meeting to Review Eteplirsen as a Treatment for Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping
3/14/2016 8:30:00 AM - Business Wire
▲8.64 % Price Change since this news event. The Volume Ratio is 1.16.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Sarepta Therapeutics Announces Long Term Plan to Consolidate Facilities within Massachusetts
3/8/2016 5:15:00 PM - Business Wire
▲20.06 % Price Change since this news event. The Volume Ratio is 1.23.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2015 Financial Results and Recent Corporate Developments
2/25/2016 4:06:00 PM - Business Wire
▲24.83 % Price Change since this news event. The Volume Ratio is 1.46.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day